Balancing Compliance and Operational Efficiency

The head of IT Quality is responsible for interacting with both IT and the business,keeping up with regulatory changes and addressing process improvements. Regulators want to ensure that pharmaceutical companies do not have an IT Quality organization that functions independent of GxP Quality, but rather, as a component of the company’s Quality structure. For this reason, the IT Quality head should have an organizational connection such as a dotted line into the GxP Quality organization so that the two stay connected.

This is important because when FDA performs an audit they consider the GxP Quality organization responsible for overall compliance, so the two must work well together. FDA audits of a pharmaceutical company’s IT system aren’t uncommon and can lead to an examination of operational, validation,and other supporting documentation.

First and foremost, it is important to have the right people in place. Consider the type of culture that best supports a quality mindset. In the pharmaceutical industry we like to look for people that have a background in pharmaceutical manufacturing. We feel these employees have the right culture already established.

In the past, it was widely accepted that IT skills are highly transferable across industries. For this reason, pharmaceutical companies often hired people who came out of varied industries. However, we learned over time that it’s a bit of a culture shock for those employees who are not used to the level of regulatory scrutiny in our industry, due to the added level of documentation and controls that are required. As an example, many of them weren’t prepared for the rigors of GxP change control.

The evolution of the pharmaceutical business has driven the replacement of manual processes and paper based systems with electronic computer systems. As an example, CSL Behring’s subsidiary, CSL Plasma, automated the majority of their manual systems with an electronic computer system resulting inbetter regulatory compliance along with significant efficiency gains. Regulators may still look at SOPs, but instead of paper forms and other documentation, we direct them to our computer system in which these documents are maintained electronically in a compliant GxP environment.

The fact is—some of the best technical folks are often lousy at documentation. It takes the full package to be the kind of person needed to maintain systems in a pharmaceutical business. At the end of the day, we have systems that can truly impact the efficacy of the products we produce, and that people are putting in their effort. This is why we must hold to such a high standard.

One of the big challenges in IT is finding and retaining good talent. There’s more demand than supply right now. The fact that we need to drill further down in the recruiting process for pharma experience makes it that much more difficult, as the pool of qualified candidates is further reduced.

We continue to evolve and are making good progress as an industry. Regulators are developing a better understanding of electronic systems, and IT leaders are developing a better understanding of the importance of maintaining complaint systems. This is a good thing for the industry and for business. You’re able to leverage the capabilities of an IT organization to make a difference and impact the productivity of the company.